Literature DB >> 18841071

Granulocyte colony-stimulating factor reduces mortality by suppressing ventricular arrhythmias in acute phase of myocardial infarction in rats.

Marcelo P Baldo1, Ana Paula C Davel, José E Nicoletti-Carvalho, Silvana Bordin, Luciana V Rossoni, José G Mill.   

Abstract

Our aim was to evaluate the effects of granulocyte colony-stimulating factor (G-CSF) on early cardiac arrhythmias after myocardial infarction (MI) and the impact on survival. Male Wistar rats received repeated doses of 50 mug/kg G-CSF (MI-GCSF group) or vehicle (MI group) at 7, 3, and 1 days before surgery. MI was induced by permanent occlusion of left coronary artery. The electrocardiogram was obtained before occlusion and then for 30 minutes after surgery. Events and duration of ventricular arrhythmias were analyzed. The levels of connexin43 (Cx43) were measured by Western blot immediately before MI production. Survival was significantly increased in MI-GCSF pretreated group (74% versus 52.9% MI, P < 0.05). G-CSF pretreatment also significantly reduced the ventricular premature beats when compared with the untreated-MI group (201 +/- 47 versus 679 +/- 117, P < 0.05). The number and the duration of ventricular tachycardia were smaller in the MI-G-CSF group, as well as the number of ventricular fibrillation episodes (10% versus 69% in MI, P < 0.05). Cx43 levels were significantly increased by G-CSF treatment (1.27 +/- 0.13 versus 0.86 +/- 0.11; P < 0.05). The MI size 24 hours after occlusion was reduced by G-CSF pretreatment (36 +/- 3% versus 44 +/- 2% of left ventricle in MI group; P < 0.05). The increase of Cx43 expression in the heart may explain the reduced incidence in ventricular arrhythmias in the early phases after coronary artery occlusion in rats, thus increasing survival after MI.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18841071     DOI: 10.1097/FJC.0b013e31818a2bb0

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  6 in total

Review 1.  Granulocyte colony-stimulating factor for ischemic heart failure: should we use it?

Authors:  Marcelo Perim Baldo; Sérgio Lamêgo Rodrigues; José Geraldo Mill
Journal:  Heart Fail Rev       Date:  2010-11       Impact factor: 4.214

Review 2.  Vascular repair and regeneration as a therapeutic target for pulmonary arterial hypertension.

Authors:  Laszlo Farkas; Martin Kolb
Journal:  Respiration       Date:  2013-03-22       Impact factor: 3.580

3.  Acute effects of granulocyte colony-stimulating factor on early ventricular arrhythmias after coronary occlusion in rats.

Authors:  Marcelo Perim Baldo; Sérgio Lamêgo Rodrigues; José Geraldo Mill
Journal:  J Pharmacol Pharmacother       Date:  2012-01

4.  The IK1/Kir2.1 channel agonist zacopride prevents and cures acute ischemic arrhythmias in the rat.

Authors:  Xu-Wen Zhai; Li Zhang; Yun-Fei Guo; Ying Yang; Dong-Ming Wang; Yan Zhang; Pan Li; Yi-Fan Niu; Qi-Long Feng; Bo-Wei Wu; Ji-Min Cao; Qing-Hua Liu
Journal:  PLoS One       Date:  2017-05-18       Impact factor: 3.240

5.  Time course of changes in heart rate and blood pressure variability in rats with myocardial infarction.

Authors:  R Aires; E B Pimentel; L Forechi; E M Dantas; J G Mill
Journal:  Braz J Med Biol Res       Date:  2017-01-09       Impact factor: 2.590

6.  Magnesium sulfate protects the heart against carbon monoxide-induced cardiotoxicity in rats.

Authors:  Kaveh Tabrizian; Hamideh Khodayari; Ramin Rezaee; Hosseinali Jahantigh; Gholamreza Bagheri; Konstantinos Tsarouhas; Mahmoud Hashemzaei
Journal:  Res Pharm Sci       Date:  2018-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.